SEC Form 4 · accession 0001626533-17-000018
Cell MedX Corp. · CMXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yanika S Silina
Officer — CFO · Director
Period of report
Aug 24, 2017
Accepted (ET)
Oct 18, 2017 · 2:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001493712
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options | $0.35 | Aug 24, 2017 | A | 300,000 | A | Aug 24, 2017 | Aug 24, 2022 | Common Shares | 300,000 | 300,000 | D |